O	0	8	Deletion	Deletion	NN	B-NP
O	9	11	of	of	IN	B-PP
O	12	19	guanine	guanine	NN	B-NP
O	20	30	nucleotide	nucleotide	NN	I-NP
O	31	38	binding	binding	NN	I-NP
O	39	46	protein	protein	NN	I-NP
O	47	52	alpha	alpha	NN	I-NP
O	53	54	z	z	NN	I-NP
O	55	62	subunit	subunit	NN	I-NP
O	63	65	in	in	IN	B-PP
O	66	70	mice	mouse	NNS	B-NP
O	71	78	induces	induce	VBZ	B-VP
O	79	80	a	a	DT	B-NP
O	81	85	gene	gene	NN	I-NP
O	86	90	dose	dose	NN	I-NP
O	91	100	dependent	dependent	JJ	I-NP
O	101	110	tolerance	tolerance	NN	I-NP
O	111	113	to	to	TO	B-PP
O	114	122	morphine	morphine	NN	B-NP
O	122	123	.	.	.	O

O	124	127	The	The	DT	B-NP
O	128	137	mechanism	mechanism	NN	I-NP
O	138	148	underlying	underlie	VBG	B-VP
O	149	152	the	the	DT	B-NP
O	153	164	development	development	NN	I-NP
O	165	167	of	of	IN	B-PP
O	168	177	tolerance	tolerance	NN	B-NP
O	178	180	to	to	TO	B-PP
O	181	189	morphine	morphine	NN	B-NP
O	190	192	is	be	VBZ	B-VP
O	193	198	still	still	RB	B-ADVP
O	199	211	incompletely	incompletely	RB	B-VP
O	212	222	understood	understand	VBN	I-VP
O	222	223	.	.	.	O

O	224	232	Morphine	Morphine	NN	B-NP
O	233	238	binds	bind	VBZ	B-VP
O	239	241	to	to	TO	B-PP
O	242	248	opioid	opioid	JJ	B-NP
O	249	258	receptors	receptor	NNS	I-NP
O	258	259	,	,	,	O
O	260	265	which	which	WDT	B-NP
O	266	268	in	in	IN	B-PP
O	269	273	turn	turn	NN	B-NP
O	274	283	activates	activate	VBZ	B-VP
O	284	294	downstream	downstream	RB	B-NP
O	295	301	second	second	JJ	I-NP
O	302	311	messenger	messenger	NN	I-NP
O	312	320	cascades	cascade	NNS	I-NP
O	321	328	through	through	IN	B-PP
O	329	343	heterotrimeric	heterotrimeric	JJ	B-NP
O	344	351	guanine	guanine	NN	I-NP
O	352	362	nucleotide	nucleotide	NN	I-NP
O	363	370	binding	binding	NN	I-NP
O	371	379	proteins	protein	NNS	I-NP
O	380	381	(	(	(	O
O	381	382	G	G	NN	B-NP
O	383	391	proteins	protein	NNS	I-NP
O	391	392	)	)	)	O
O	392	393	.	.	.	O

O	394	396	In	In	IN	B-PP
O	397	401	this	this	DT	B-NP
O	402	407	paper	paper	NN	I-NP
O	407	408	,	,	,	O
O	409	411	we	we	PRP	B-NP
O	412	416	show	show	VBP	B-VP
O	417	421	that	that	IN	B-SBAR
O	422	423	G	G	NN	B-NP
O	423	424	(	(	(	O
O	424	425	z	z	NN	B-NP
O	425	426	)	)	)	O
O	426	427	,	,	,	O
O	428	429	a	a	DT	B-NP
O	430	436	member	member	NN	I-NP
O	437	439	of	of	IN	B-PP
O	440	443	the	the	DT	B-NP
O	444	454	inhibitory	inhibitory	JJ	I-NP
O	455	456	G	G	NN	I-NP
O	457	464	protein	protein	NN	I-NP
O	465	471	family	family	NN	I-NP
O	471	472	,	,	,	O
O	473	478	plays	play	VBZ	B-VP
O	479	481	an	an	DT	B-NP
O	482	491	important	important	JJ	I-NP
O	492	496	role	role	NN	I-NP
O	497	499	in	in	IN	B-PP
O	500	509	mediating	mediate	VBG	B-VP
O	510	513	the	the	DT	B-NP
O	514	523	analgesic	analgesic	JJ	I-NP
O	524	527	and	and	CC	I-NP
O	528	537	lethality	lethality	NN	I-NP
O	538	545	effects	effect	NNS	I-NP
O	546	548	of	of	IN	B-PP
O	549	557	morphine	morphine	NN	B-NP
O	558	563	after	after	IN	B-PP
O	564	573	tolerance	tolerance	NN	B-NP
O	574	585	development	development	NN	I-NP
O	585	586	.	.	.	O

O	587	589	We	We	PRP	B-NP
O	590	597	blocked	block	VBD	B-VP
O	598	607	signaling	signaling	NN	B-NP
O	608	615	through	through	IN	B-PP
O	616	619	the	the	DT	B-NP
O	620	621	G	G	NN	I-NP
O	621	622	(	(	(	O
O	622	623	z	z	NN	B-NP
O	623	624	)	)	)	O
O	625	631	second	second	JJ	B-NP
O	632	641	messenger	messenger	NN	I-NP
O	642	649	cascade	cascade	NN	I-NP
O	650	652	by	by	IN	B-PP
O	653	660	genetic	genetic	JJ	B-NP
O	661	669	ablation	ablation	NN	I-NP
O	670	672	of	of	IN	B-PP
O	673	676	the	the	DT	B-NP
O	677	682	alpha	alpha	NN	I-NP
O	683	690	subunit	subunit	NN	I-NP
O	691	693	of	of	IN	B-PP
O	694	697	the	the	DT	B-NP
O	698	699	G	G	NN	I-NP
O	700	707	protein	protein	NN	I-NP
O	708	710	in	in	IN	B-PP
O	711	715	mice	mouse	NNS	B-NP
O	715	716	.	.	.	O

O	717	720	The	The	DT	B-NP
O	721	727	Galpha	Galpha	NN	I-NP
O	727	728	(	(	(	O
O	728	729	z	z	NN	B-NP
O	729	730	)	)	)	O
O	731	739	knockout	knockout	NN	B-NP
O	740	745	mouse	mouse	NN	I-NP
O	746	754	develops	develop	VBZ	B-VP
O	755	768	significantly	significantly	RB	B-NP
O	769	778	increased	increase	VBN	I-NP
O	779	788	tolerance	tolerance	NN	I-NP
O	789	791	to	to	TO	B-PP
O	792	800	morphine	morphine	NN	B-NP
O	800	801	,	,	,	O
O	802	807	which	which	WDT	B-NP
O	808	815	depends	depend	VBZ	B-VP
O	816	818	on	on	IN	B-PP
O	819	825	Galpha	Galpha	NN	B-NP
O	825	826	(	(	(	O
O	826	827	z	z	NN	B-NP
O	827	828	)	)	)	O
O	829	833	gene	gene	NN	B-NP
O	834	840	dosage	dosage	NN	I-NP
O	840	841	.	.	.	O

O	842	849	Further	Further	JJ	B-NP
O	850	861	experiments	experiment	NNS	I-NP
O	862	873	demonstrate	demonstrate	VBP	B-VP
O	874	878	that	that	IN	B-SBAR
O	879	882	the	the	DT	B-NP
O	883	891	enhanced	enhance	VBN	I-NP
O	892	900	morphine	morphine	NN	I-NP
O	901	910	tolerance	tolerance	NN	I-NP
O	911	913	is	be	VBZ	B-VP
O	914	917	not	not	RB	I-VP
O	918	924	caused	cause	VBN	I-VP
O	925	927	by	by	IN	B-PP
O	928	943	pharmacokinetic	pharmacokinetic	JJ	B-NP
O	944	947	and	and	CC	I-NP
O	948	959	behavioural	behavioural	JJ	I-NP
O	960	968	learning	learning	NN	I-NP
O	969	979	mechanisms	mechanism	NNS	I-NP
O	979	980	.	.	.	O

O	981	984	The	The	DT	B-NP
O	985	992	results	result	NNS	I-NP
O	993	1000	suggest	suggest	VBP	B-VP
O	1001	1005	that	that	IN	B-SBAR
O	1006	1007	G	G	NN	B-NP
O	1007	1008	(	(	(	O
O	1008	1009	z	z	NN	B-NP
O	1009	1010	)	)	)	O
O	1011	1020	signaling	signaling	NN	B-NP
O	1021	1029	pathways	pathway	NNS	I-NP
O	1030	1033	are	be	VBP	B-VP
O	1034	1042	involved	involve	VBN	I-VP
O	1043	1045	in	in	IN	B-PP
O	1046	1057	transducing	transduce	VBG	B-VP
O	1058	1061	the	the	DT	B-NP
O	1062	1071	analgesic	analgesic	JJ	I-NP
O	1072	1075	and	and	CC	I-NP
O	1076	1085	lethality	lethality	NN	I-NP
O	1086	1093	effects	effect	NNS	I-NP
O	1094	1096	of	of	IN	B-PP
O	1097	1105	morphine	morphine	NN	B-NP
O	1106	1115	following	follow	VBG	B-PP
O	1116	1123	chronic	chronic	JJ	B-NP
O	1124	1132	morphine	morphine	NN	I-NP
O	1133	1142	treatment	treatment	NN	I-NP
O	1142	1143	.	.	.	O

